Take Aim at Cancer Founder to Speak at American Association for Cancer Research Annual Meeting
ATLANTA - Apr. 13, 2010 - Sunday, April 18th, at the Washington Convention Center in Washington, D.C., Take Aim at Cancer founder and cancer survivor, Jeff Wigbels, will participate in a panel discussion for the news media at the American Association for Cancer Research (AACR) Annual Meeting. The session, entitled “Personalized Therapy of Advanced Non-Small Cell Lung Cancer,” will be co-chaired by Dr. Roy S. Herbst, professor in the Department of Thoracic/Head and Neck Medical Oncology at the University of Texas M. D. Anderson Cancer Center (MDACC), and co-principal investigator in MDACC’s groundbreaking study launched in 2006 called BATTLE – Biomarker-based Approaches of Targeted Therapy for Lung Cancer Elimination.
As a patient of Dr. Herbst and participant in BATTLE since the program’s inception in 2006, Wigbels will be representing the patient perspective in presenting the success of these first-ever clinical trials to test biomarker-based, personalized therapies in patients with advanced, treatment resistant lung cancer. “Dr. Herbst and his team have given me the greatest gift I could have ever imagined when I was diagnosed four years ago: the gift of life,” says Wigbels. “It is truly an honor and a blessing to be able to sit among them on this panel and share with the cancer research world the promising results of BATTLE.”
The AACR Annual Meeting attracts more than 17,000 participants who share the latest discoveries and developments in the cancer research field. This year marks the 101st Annual Meeting.
About the Take Aim at Cancer Research Fund: The mission of the TACRF is to raise funds to support groundbreaking research and make individualized, targeted therapy available to more people battling cancer. 100% of all proceeds go directly to fund research. TakeAimAtCancer.org.
About the American Association for Cancer Research: The mission of the AACR is to prevent and cure cancer. Founded in 1907, the AACR is the world’s oldest and largest professional organization dedicated to advancing cancer research. The membership includes 30,000 basic, translational and clinical researchers; health care professionals; and cancer survivors and advocates in the United States and more than 90 other countries.
Source: Take Aim at Cancer Research Fund